The prevalence of co-administration of clopidogrel and proton pump inhibitors

Author： Shrestha Kajal   Hughes Jeffery David   Lee Ya Ping   Parsons Richard  

Publisher： Radcliffe Press

ISSN： 1479-1064

Source： Quality in Primary Care, Vol.19, Iss.1, 2011-02, pp. : 35-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients

By Mahabaleshwarkar Rohan K.   Yang Yi   Datar Manasi V.   Bentley John P.   Strum Matthew W.   Banahan Benjamin F.   Null Kyle D.  

Current Medical Research and Opinion, Vol. 29, Iss. 4, 2013-04 ,pp. : 315-323

Informa Healthcare

Access to resources Recommend Favorite

Editorial: proton pump inhibitors in cirrhosis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 6, 2015-03 ,pp. : 592-592

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proton pump inhibitors and hypomagnesemia in patients with arrhythmias

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 12, 2015-12 ,pp. : 1525-1526

John Wiley & Sons Inc

Access to resources Recommend Favorite

We must be judicious when prescribing proton-pump inhibitors

By Deshpande Amar  

Therapy, Vol. 7, Iss. 5, 2010-09 ,pp. : 543-545

Future Medicine

Access to resources Recommend Favorite

Reducing the cost of proton pump inhibitors by adopting best practice

By Hughes Jeffery D   Tanpurekul Wanitchaya   Keen Neil C   Ee Hooi C  

Quality in Primary Care, Vol. 17, Iss. 1, 2009-02 ,pp. : 15-21

Radcliffe Press

Access to resources Recommend Favorite